Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Employees must remain with Autolus through the applicable vesting dates to receive their awards.

Rhea-AI Summary

Autolus Therapeutics (AUTL) granted employee stock options and restricted stock units under its inducement plan, with a grant date of October 21, 2026. Awards to 15 employees comprise options to purchase 75,400 American Depositary Shares and 129,310 restricted stock units, each representing an equal number of ordinary shares.

The options have a $1.66 per-share exercise price, equal to the October 20 closing stock price, and a ten-year term. Options vest over four years, while restricted stock units vest in four equal annual installments. The awards were granted under the 2025 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

Positive

• None.

Negative

• Minor point. Forward-looking: it has not happened yet and may not happen.Options for 75,400 American Depositary Shares at $1.66 per share create potential dilution upon exercise.
• Minor point. Forward-looking: it has not happened yet and may not happen.129,310 restricted stock units represent potential dilution as awards vest.

Key Figures

Stock options awarded: 75,400 American Depositary Shares RSUs awarded: 129,310 restricted stock units Employees receiving grants: 15 employees +4 more

Stock options awarded

75,400 American Depositary Shares

Inducement grants to employees

RSUs awarded

129,310 restricted stock units

Inducement grants to employees

Employees receiving grants

15 employees

Inducement grants

Option exercise price

$1.66 per share

Equal to the October 20, 2026 closing price

Option term

10 years

Stock option awards

Option vesting

25% after 1 year; remainder in 36 monthly installments

Stock option awards

RSU vesting

4 equal annual installments

Restricted stock units

Key Terms

american depositary shares, restricted stock units, nasdaq listing rule 5635(c)(4)

3 terms

american depositary shares financial

"awards to purchase an aggregate of 75,400 American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

restricted stock units financial

"129,310 restricted stock units (RSUs)"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON and GAITHERSBURG, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 75,400 American Depositary Shares and 129,310 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 15 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock option awards and RSUs have a grant date of October 21, 2026. The stock option awards have an exercise price of $1.66 per share, which is equal to the closing price of Autolus’ common stock on October 20, 2026. Each stock option award has a ten-year term and vests over four years, with 25% of the original number of shares vesting on the one-year anniversary of the hire date of the employee and the remainder vesting in 36 equal monthly installments thereafter. Each RSU vests in four equal annual installments. The options and RSUs are subject to the employee's continued service with Autolus through the applicable vesting dates.

About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has a marketed therapy and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com.

Contact:

Amanda Cray 
Executive Director, Investor Relations & External Communications
+1 617-967-0207 
a.cray@autolus.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What employee inducement awards did Autolus grant in October 2026?

Autolus granted 15 employees options to purchase 75,400 American Depositary Shares and 129,310 restricted stock units, with a grant date of October 21, 2026. The options have an exercise price of $1.66 per share and a ten-year term.

How do Autolus employee inducement awards vest?

Options vest 25% on the first anniversary of the employee's hire date, with the remainder vesting in 36 equal monthly installments thereafter. Restricted stock units vest in four equal annual installments. Both types of awards require continued service with Autolus through the applicable vesting dates.